The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
Subscribe To Our Newsletter & Stay Updated
